Brooklyn ImmunoTherapeutics, Inc. (BTX) has 56 open-market insider trades by 26 insiders since 2010. The most active filer is Alfred D. Kingsley.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Neal C. Bradsher | Dir10% Owner | — | 5 | $18.0M | 2019-04-16 |
| Broadwood Partners L.P. | Dir10% Owner | — | 5 | $17.6M | 2016-06-21 |
| Broadwood Partners, L.P. | Dir10% Owner | — | 2 | $12.4M | 2017-07-31 |
| Broadwood Capital Inc. via Neal C. Bradsher | 10% | — | 3 | $6.8M | 2019-03-08 |
| Charles Cherington | Dir10% Owner | — | 1 | $6.3M | 2021-06-17 |
| Alfred D. Kingsley | — | — | 7 | $4.7M | 2019-03-08 |
| George P. Denny III | 10% Owner | — | 1 | $1.2M | 2021-07-14 |
| Michael D. West | CEO | — | 4 | $805K | 2018-09-17 |
| Stephen C. Farrell | Dir | — | 4 | $350K | 2015-11-06 |
| Robert Peabody | COOSr. VPand CFO | — | 2 | $289K | 2014-07-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert W. Fairbairn | Director | Sell | $286K | 2025-12-18 |
| George P. Denny III | 10% | Buy | $40 | 2021-07-08 |
| George P. Denny III | 10% Owner | Sell | $1.2M | 2021-07-06 |
| Charles Cherington | Director & 10% Owner | Sell | $6.3M | 2021-06-16 |
| Deborah J. Andrews | Director | Buy | $4K | 2018-09-11 |
| Neal C. Bradsher | Director & 10% Owner | Buy | $14.0M |
Companies that share insiders with BTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-10-13 |
| Russell Skibsted | CFO | Buy | $5K | 2017-08-23 |
| Michael D. West | CEO | Buy | $5K | 2017-08-22 |
| Neal C. Bradsher | Director & 10% | Buy | $26K | 2017-08-22 |
| Aditya P. Mohanty | CEO | Buy | $19K | 2017-08-21 |
| Deborah J. Andrews | Director | Buy | $6K | 2017-08-21 |
| Stephana Eilene Patton | General Counsel | Buy | $19K | 2017-08-21 |
| Alfred D. Kingsley | — | Sell | $420K | 2017-07-31 |
| Deborah J. Andrews | Director | Buy | $6K | 2017-06-16 |
| Deborah J. Andrews | Director | Buy | $6K | 2017-05-16 |